Teneligliptin hydrobromide hydrate
Modify Date: 2024-01-08 11:33:43
Teneligliptin hydrobromide hydrate structure
|
Common Name | Teneligliptin hydrobromide hydrate | ||
|---|---|---|---|---|
| CAS Number | 1572583-29-9 | Molecular Weight | 1275.731 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H30N6OS | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Teneligliptin hydrobromide hydrateTeneligliptin hydrobromide hydrate is a potent chemotype prolylthiazolidine-based DPP-4 inhibitor, which competitively inhibits human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50s of approximately 1 nM[1]. |
| Name | Teneligliptin sesquihydrobromide hydrate |
|---|---|
| Synonym | More Synonyms |
| Description | Teneligliptin hydrobromide hydrate is a potent chemotype prolylthiazolidine-based DPP-4 inhibitor, which competitively inhibits human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50s of approximately 1 nM[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C22H30N6OS |
|---|---|
| Molecular Weight | 1275.731 |
| Exact Mass | 1270.081665 |
| Storage condition | 2-8℃ |
| Teneligliptin sesquihydrobromide hydrate |
| Methanone, [(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]-3-thiazolidinyl-, hydrobromide, hydrate (2:5:1) |
| {(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl}(1,3-thiazolidin-3-yl)methanone hydrobromide hydrate (2:5:1) |